Partnership to Address Lab Needs

(Milan, Italy) will partner on developing new laboratory equipment, and Abbott obtains nonexclusive rights to distribute and market laboratory automation equipment manufactured by Inpeco.

Specifically, Abbott and Inpeco will partner to design, develop, and commercialize interfaces between Abbott's Architect and Cell-DYN family of analyzers and Inpeco's suite of modular, laboratory automation components to create an enhanced analytic workcell, an immunochemistry track workcell, a hematology track workcell, or a customized combination of all three.

Abbott will have access to new laboratory technologies developed by Inpeco, giving Abbott the ability to incorporate technologic advancements, including information technology and robotics, into future automation products. Abbott plans to offer a suite of automation solutions that can be customized to address key needs within the laboratory, improving the consistency and efficiency of diagnostic testing.

An important player in the clinical laboratory market and the life sciences, Inpeco specializes in the development, production, distribution, and servicing of products to improve laboratory operations. Its current line is the result of a 10-year R&D program conducted with diagnostic and pharmaceutical partners.

"By working with Abbott, we're able to provide a new level of automation for diagnostic laboratories that capitalizes on the strengths of Abbotts' diagnostic instruments,” said Andrea Pedrazzini, president and CEO of Inpeco.



Related Links:
Abbott
Inpeco